Salt Lake City, UT, United States of America

Michael Haines

USPTO Granted Patents = 1 

Average Co-Inventor Count = 26.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Haines: Innovator in Machine Learning and Perturbation Data Synthesis

Introduction

Michael Haines is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of machine learning, particularly in the synthesis of perturbation data. His innovative work has led to the development of advanced graphical user interfaces that enhance the understanding of cellular perturbations.

Latest Patents

Haines holds a patent titled "Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces." This patent focuses on systems, non-transitory computer-readable media, and methods for embedding perturbation data via a machine learning model. The technology filters, aligns, and aggregates embeddings to create a genome-wide perturbation database for real-time generation of perturbation heatmaps. The systems can receive a variety of perturbation images portraying cells from multiple wells, generate well-level image embeddings, and align these embeddings to produce aligned well-level image embeddings. Furthermore, the systems can aggregate these embeddings according to perturbations from various experiments, ultimately generating perturbation comparisons.

Career Highlights

Michael Haines is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in machine learning to advance pharmaceutical research. His work is instrumental in developing innovative solutions that leverage data to improve drug discovery processes.

Collaborations

Haines collaborates with talented individuals such as Marta Marie Fay and August Orvis Allen, contributing to a dynamic team focused on pushing the boundaries of pharmaceutical technology.

Conclusion

Michael Haines is a key figure in the intersection of machine learning and pharmaceutical innovation. His patent and ongoing work at Recursion Pharmaceuticals, Inc. exemplify his commitment to advancing the field through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…